Author:
Davies Andrea,Hayes Alison K.,Knight Katy,Watmough Sarah J.,Pirmohamed Munir,Clark Richard E.
Subject
Cancer Research,Oncology,Hematology
Reference38 articles.
1. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia;Druker;N Engl J Med,2006
2. Characterisation of AMN107, a selective inhibitor of native and mutant BCR-ABL;Weisberg;Cancer Cell,2005
3. Overriding imatinib resistance with a novel ABL kinase inhibitor;Shah;Science,2004
4. Metabolism and disposition of dasatinib after oral administration to humans;Christopher;Drug Metab Dispos,2008
5. Tasigna (nilotinib) [package insert]. East hanover, NJ: Novartis Pharmaceuticals Corporation; October 2007. http://www.fda.gov/cder/foi/label/2007/022068lbl.pdf. Accessed 28th April 2009.
Cited by
48 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献